Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
2.135 USD | +3.64% | -14.96% | -14.61% |
Kurzporträt
Mitarbeiterzahl: 66
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Mark Litton
CEO | Chief Executive Officer | 56 | 11.07.19 |
Andrew Gengos
DFI | Director of Finance/CFO | 59 | 18.05.23 |
Rachel Lenington
COO | Chief Operating Officer | 51 | 14.06.21 |
Kevin Church
CTO | Chief Tech/Sci/R&D Officer | 39 | 01.01.16 |
Julie Rathbun
IRC | Investor Relations Contact | - | - |
Robert Renninger
PRN | Corporate Officer/Principal | - | 01.07.20 |
Samantha Willing
HRO | Human Resources Officer | - | 01.02. |
Mark Worthington
LAW | General Counsel | 58 | 01.06.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Grant Pickering
BRD | Director/Board Member | 56 | 27.01.22 |
John Fluke
BRD | Director/Board Member | 81 | 01.01.13 |
Joseph Edelman
BRD | Director/Board Member | 67 | 01.05.20 |
James Johnson
BRD | Director/Board Member | 67 | 01.08.20 |
Barbara Kosacz
BRD | Director/Board Member | 66 | 08.03.21 |
Mark Litton
CEO | Chief Executive Officer | 56 | 11.07.19 |
Michael Panzara
BRD | Director/Board Member | 57 | 18.03.22 |
Kelly Romano
CHM | Chairman | 62 | 14.12.20 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 38 326 652 | 31 801 261 ( 82,97 %) | 0 | 82,97 % |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-14.61% | 78.95 Mio. | |
-1.22% | 41.35 Mrd. | |
+42.27% | 40.38 Mrd. | |
+3.41% | 39.05 Mrd. | |
-12.11% | 26.67 Mrd. | |
+2.46% | 24.07 Mrd. | |
-23.65% | 18.36 Mrd. | |
-3.93% | 11.68 Mrd. | |
+22.31% | 11.6 Mrd. | |
+7.67% | 11.15 Mrd. |
- Börse
- Aktien
- A2QCFW Aktie
- Unternehmen Athira Pharma, Inc.